Anxiety and depression overlap

The overlap rate depends on what you count and when. Point-in-time comorbidity, meaning both conditions present at the same time, is roughly 60 to 70 percent among adults with current major depression. Lifetime comorbidity, meaning both conditions at some point in a person's history, is higher: NCS-R analyses put it at roughly 75 percent for major depression with any anxiety disorder. The single most-cited current-comorbidity paper is Lamers and colleagues' 2011 analysis of the Netherlands Study of Depression and Anxiety (NESDA).

The STAR*D study, the largest US effectiveness trial in depression treatment, followed more than 4,000 adults through sequential antidepressant treatment. Fava and colleagues found that anxious depression, defined by a high anxiety-symptom score at baseline, was associated with lower remission rates, slower response, and higher side-effect burden than non-anxious depression, at every level of treatment. Longitudinal cohorts consistently show longer episode duration, more functional impairment, and higher relapse rates in comorbid presentations.

SSRIs and SNRIs are first-line for both major depression and every common anxiety disorder in US and international guidelines. CBT is first-line for both, though the specific protocols differ (exposure-focused for anxiety, behavioral-activation and cognitive-restructuring emphasis for depression). This makes treatment planning simpler for comorbid presentations than for other combinations. When one first-line option works for both conditions, sequencing becomes a matter of clinical fit rather than choosing between two different treatment traditions.

The overlap describes group-level averages. It doesn't establish that anxiety and depression share a single underlying cause. The evidence supports a dimensional view in which shared risk factors, including neuroticism and shared environmental stressors, contribute to both, alongside condition-specific factors. Whether anxiety and depression represent one disorder with two presentations, or two disorders with overlapping mechanisms, remains debated in the research literature.

Anxiety and depression overlap heavily. National survey data show that a large share of adults who meet criteria for a major depressive episode in a given year also meet criteria for at least one anxiety disorder, and a large share of people with an anxiety disorder experience depression. The National Comorbidity Survey Replication, the survey that gives the word 'comorbidity' its place in this field, documented the overlap in detail, and Lamers and colleagues' analysis of the Netherlands Study of Depression and Anxiety put the current comorbidity at roughly two-thirds of adults with major depression.

The overlap isn't only common, it's consequential. Comorbid anxiety and depression is associated with greater symptom severity, more functional impairment, a longer time to remission, and a higher risk of relapse than either condition alone. The STAR*D study, the largest US effectiveness trial of sequential antidepressant treatment, found that anxious depression, meaning depression with a high anxiety-symptom score, was associated with lower remission rates and slower response across levels of treatment. The two conditions also share symptoms, including sleep disturbance, difficulty concentrating, and irritability, which can make them hard to separate in an individual presentation.

Because the overlap is so common, treatment guidance increasingly favors approaches that address both conditions. The first-line treatments overlap as well, since SSRIs, SNRIs, and CBT all have evidence in both anxiety and depression, which simplifies treatment when the two co-occur. See the evidence summaries on CBT for anxiety and SSRIs and SNRIs for anxiety for the treatment-side detail.

Estimates of the overlap vary with definitions, time windows, and survey methods. Read the overlap as a strong and consistent pattern rather than a single fixed rate.

Anxious depression is a specification of major depression with prominent anxiety features; the DSM-5-TR includes it as a modifier.